Daniel R. Chevallard, CFO and COO: Viracta Therapeutics VIRX Sell · Filed 23/11/28

Trade details

Type: Insider sale
Amount: $1,860
Shares · price: 3,720 sh · $0.50 a share
Held after: 98,822 sh
Stock: Viracta Therapeutics VIRX
Person: Daniel R. ChevallardCFO and COO
Trade date: 23/11/28
Filed: 23/11/28
Days to filing: 0 days

Sold 3.6% of holdings

Share of holding sold: 3.6%

Viracta Therapeutics trades, last 26 weeks

What else happened in Viracta Therapeutics around then

Filed or reported within 30 days of the trade day · 23/10/29~23/12/28

Daniel R. Chevallard's recent trades

Daniel R. ChevallardCFO
BuyLenz Therapeutics
Buy
Lenz Therapeutics
LENZ
$64.3K
7,500 sh
$64.3K
Filed 03/30
Traded 03/27
Daniel R. ChevallardCFO
BuyLenz Therapeutics
Buy
Lenz Therapeutics
LENZ
$49.6K
2,178 sh
$49.6K
Filed 25/11/07
Traded 25/11/07
Daniel R. ChevallardCFO
BuyLenz Therapeutics
Buy
Lenz Therapeutics
LENZ
$454
20 sh
$454
Filed 25/11/07
Traded 25/11/07
Daniel R. ChevallardCFO
BuyLenz Therapeutics
Buy
Lenz Therapeutics
LENZ
$50K
3,188 sh
$50K
Filed 24/05/15
Traded 24/05/14
Daniel R. ChevallardCFO and COO
SellViracta Therapeutics
Sell
Viracta Therapeutics
VIRX
$2,486
3,405 sh
$2,486
Filed 24/02/27
Traded 24/02/27